Table 2.

Consensus regions in 53 patients with MCL


Chromosomal band

Minimal segment of genomic gain/loss, Mbp

Approximate size, Mbp

No. of cases

Candidate genes
–8p21   20.7-23.1   2.4   18  TNFRSF10B 
–9p21-9p22   14.3-26.5   12.2   19  CDKN2A, CDKN2B 
–10p14-10p15   0.0-12.4   12.4   11   —  
+10p13   22.1-24.8   2.7   6  BMI1 
+11q13   63.9-65.3   1.4   6  RELA, MAP4K2 
+11q13   66.5-71.7   5.2   6  CCND1, FGF3, FGF4 
–11q22-11q23   108.0-109.7   1.7   23  ATM, DDX10 
+11q23   115.9-123.0   7.1   4  MLL 
–12p11-12p13   10.2-21.8   11.6   9  CDKN1B 
–13q14   48.1-48.5   0.4   29  RFP2, BCMSUN 
–13q33-13q34   102.2-109.1   6.9   26   —  
+18q21
 
55.3-64.6
 
9.3
 
8
 
BCL2
 

Chromosomal band

Minimal segment of genomic gain/loss, Mbp

Approximate size, Mbp

No. of cases

Candidate genes
–8p21   20.7-23.1   2.4   18  TNFRSF10B 
–9p21-9p22   14.3-26.5   12.2   19  CDKN2A, CDKN2B 
–10p14-10p15   0.0-12.4   12.4   11   —  
+10p13   22.1-24.8   2.7   6  BMI1 
+11q13   63.9-65.3   1.4   6  RELA, MAP4K2 
+11q13   66.5-71.7   5.2   6  CCND1, FGF3, FGF4 
–11q22-11q23   108.0-109.7   1.7   23  ATM, DDX10 
+11q23   115.9-123.0   7.1   4  MLL 
–12p11-12p13   10.2-21.8   11.6   9  CDKN1B 
–13q14   48.1-48.5   0.4   29  RFP2, BCMSUN 
–13q33-13q34   102.2-109.1   6.9   26   —  
+18q21
 
55.3-64.6
 
9.3
 
8
 
BCL2
 

The genomic localization information is according to the NCBI database.—indicates not applicable.

Close Modal

or Create an Account

Close Modal
Close Modal